Study of the Stability of Factor VIII Activity in Human Plasma for Fractionation When Modeling Deviations in the Storage and Transportation Temperature Conditions
The European Pharmacopoeia requires that the transportation and storage of human plasma for fractionation should be carried out at –20 °C or below, while allowing for some deviations in the temperature regime. The current Russian regulatory documentation requires the transportation and storage of pl...
| Prif Awduron: | , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | Russian |
| Cyhoeddwyd: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2020-09-01
|
| Cyfres: | Биопрепараты: Профилактика, диагностика, лечение |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.biopreparations.ru/jour/article/view/285 |